BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 15142950)

  • 1. Expression of mutant p193 and p53 permits cardiomyocyte cell cycle reentry after myocardial infarction in transgenic mice.
    Nakajima H; Nakajima HO; Tsai SC; Field LJ
    Circ Res; 2004 Jun; 94(12):1606-14. PubMed ID: 15142950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional abrogation of p53 is required for T-Ag induced proliferation in cardiomyocytes.
    Huh NE; Pasumarthi KB; Soonpaa MH; Jing S; Patton B; Field LJ
    J Mol Cell Cardiol; 2001 Aug; 33(8):1405-19. PubMed ID: 11448130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breaking down cell-cycle barriers in the adult heart.
    Regula KM; Kirshenbaum LA
    Circ Res; 2004 Jun; 94(12):1524-6. PubMed ID: 15217915
    [No Abstract]   [Full Text] [Related]  

  • 4. Coexpression of mutant p53 and p193 renders embryonic stem cell-derived cardiomyocytes responsive to the growth-promoting activities of adenoviral E1A.
    Pasumarthi KB; Tsai SC; Field LJ
    Circ Res; 2001 May; 88(10):1004-11. PubMed ID: 11375269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Directed expression of dominant-negative p73 enables proliferation of cardiomyocytes in mice.
    Ebelt H; Zhang Y; Köhler K; Xu J; Gajawada P; Boettger T; Hollemann T; Müller-Werdan U; Werdan K; Braun T
    J Mol Cell Cardiol; 2008 Sep; 45(3):411-9. PubMed ID: 18634800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted expression of cyclin D2 results in cardiomyocyte DNA synthesis and infarct regression in transgenic mice.
    Pasumarthi KB; Nakajima H; Nakajima HO; Soonpaa MH; Field LJ
    Circ Res; 2005 Jan; 96(1):110-8. PubMed ID: 15576649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of p38alpha MAPK in cardiac apoptosis and remodeling after myocardial infarction.
    Ren J; Zhang S; Kovacs A; Wang Y; Muslin AJ
    J Mol Cell Cardiol; 2005 Apr; 38(4):617-23. PubMed ID: 15808838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cardiomyocyte cell cycle.
    Lafontant PJ; Field LJ
    Novartis Found Symp; 2006; 274():196-207; discussion 208-13, 272-6. PubMed ID: 17019813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiomyocyte cell cycle control and growth estimation in vivo--an analysis based on cardiomyocyte nuclei.
    Walsh S; Pontén A; Fleischmann BK; Jovinge S
    Cardiovasc Res; 2010 Jun; 86(3):365-73. PubMed ID: 20071355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioenergetic and functional consequences of bone marrow-derived multipotent progenitor cell transplantation in hearts with postinfarction left ventricular remodeling.
    Zeng L; Hu Q; Wang X; Mansoor A; Lee J; Feygin J; Zhang G; Suntharalingam P; Boozer S; Mhashilkar A; Panetta CJ; Swingen C; Deans R; From AH; Bache RJ; Verfaillie CM; Zhang J
    Circulation; 2007 Apr; 115(14):1866-75. PubMed ID: 17389266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Silent information regulator 2alpha, a longevity factor and class III histone deacetylase, is an essential endogenous apoptosis inhibitor in cardiac myocytes.
    Alcendor RR; Kirshenbaum LA; Imai S; Vatner SF; Sadoshima J
    Circ Res; 2004 Nov; 95(10):971-80. PubMed ID: 15486319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of a transgene encoding mutant p193/CUL7 preserves cardiac function and limits infarct expansion after myocardial infarction.
    Hassink RJ; Nakajima H; Nakajima HO; Doevendans PA; Field LJ
    Heart; 2009 Jul; 95(14):1159-64. PubMed ID: 19435717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclin I and p53 are differentially expressed during the terminal differentiation of the postnatal mouse heart.
    Liu Y; Tang MK; Cai DQ; Li M; Wong WM; Chow PH; Lee KK
    Proteomics; 2007 Jan; 7(1):23-32. PubMed ID: 17154274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiomyocyte-specific overexpression of human stem cell factor improves cardiac function and survival after myocardial infarction in mice.
    Xiang FL; Lu X; Hammoud L; Zhu P; Chidiac P; Robbins J; Feng Q
    Circulation; 2009 Sep; 120(12):1065-74, 9 p following 1074. PubMed ID: 19738140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of cardiomyocyte-like cells in infarct hearts by gene transfer of Gata4, Mef2c, and Tbx5.
    Inagawa K; Miyamoto K; Yamakawa H; Muraoka N; Sadahiro T; Umei T; Wada R; Katsumata Y; Kaneda R; Nakade K; Kurihara C; Obata Y; Miyake K; Fukuda K; Ieda M
    Circ Res; 2012 Oct; 111(9):1147-56. PubMed ID: 22931955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts.
    Murry CE; Soonpaa MH; Reinecke H; Nakajima H; Nakajima HO; Rubart M; Pasumarthi KB; Virag JI; Bartelmez SH; Poppa V; Bradford G; Dowell JD; Williams DA; Field LJ
    Nature; 2004 Apr; 428(6983):664-8. PubMed ID: 15034593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histone acetyltransferase activity of p300 is required for the promotion of left ventricular remodeling after myocardial infarction in adult mice in vivo.
    Miyamoto S; Kawamura T; Morimoto T; Ono K; Wada H; Kawase Y; Matsumori A; Nishio R; Kita T; Hasegawa K
    Circulation; 2006 Feb; 113(5):679-90. PubMed ID: 16461841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myocardial expression of a dominant-negative form of Daxx decreases infarct size and attenuates apoptosis in an in vivo mouse model of ischemia/reperfusion injury.
    Roubille F; Combes S; Leal-Sanchez J; Barrère C; Cransac F; Sportouch-Dukhan C; Gahide G; Serre I; Kupfer E; Richard S; Hueber AO; Nargeot J; Piot C; Barrère-Lemaire S
    Circulation; 2007 Dec; 116(23):2709-17. PubMed ID: 18025529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survivin determines cardiac function by controlling total cardiomyocyte number.
    Levkau B; Schäfers M; Wohlschlaeger J; von Wnuck Lipinski K; Keul P; Hermann S; Kawaguchi N; Kirchhof P; Fabritz L; Stypmann J; Stegger L; Flögel U; Schrader J; Fischer JW; Hsieh P; Ou YL; Mehrhof F; Tiemann K; Ghanem A; Matus M; Neumann J; Heusch G; Schmid KW; Conway EM; Baba HA
    Circulation; 2008 Mar; 117(12):1583-93. PubMed ID: 18332262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Granulocyte colony-stimulating factor treatment enhances the efficacy of cellular cardiomyoplasty with transplantation of embryonic stem cell-derived cardiomyocytes in infarcted myocardium.
    Cho SW; Gwak SJ; Kim IK; Cho MC; Hwang KK; Kwon JS; Choi CY; Yoo KJ; Kim BS
    Biochem Biophys Res Commun; 2006 Feb; 340(2):573-82. PubMed ID: 16376856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.